mRNA |
TGX221 |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.4 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.4 |
mRNA |
VX-11e |
GDSC1000 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
JW-480 |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.4 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
STF-62247 |
GDSC1000 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
BRD-K92856060 |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.4 |
mRNA |
fluvastatin |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.4 |